National Cancer Institute Thesaurus

Last uploaded: February 23, 2024
Preferred Name

Mefenamic Acid

Synonyms

2-((2,3-Dimethylphenyl)amino)benzoic Acid

Anthranilic Acid, N-2,3-xylyl-

MEFENAMIC ACID

Mefenamic Acid

Ponstel

Definitions

An anthranilic acid and non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, antipyretic and analgesic activities. Mefenamic acid inhibits the activity of the enzymes cyclo-oxygenase I and II, resulting in a decreased formation of precursors of prostaglandins and thromboxanes. The resulting decrease in prostaglandin synthesis, by prostaglandin synthase, is responsible for the therapeutic effects of mefenamic acid. Mefenamic acid also causes a decrease in the formation of thromboxane A2 synthesis, by thromboxane synthase, thereby inhibiting platelet aggregation.

ID

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C47599

CAS_Registry

61-68-7

Chemical_Formula

C15H15NO2

code

C47599

Concept_In_Subset

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63923

Contributing_Source

FDA

DEFINITION

An anthranilic acid and non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, antipyretic and analgesic activities. Mefenamic acid inhibits the activity of the enzymes cyclo-oxygenase I and II, resulting in a decreased formation of precursors of prostaglandins and thromboxanes. The resulting decrease in prostaglandin synthesis, by prostaglandin synthase, is responsible for the therapeutic effects of mefenamic acid. Mefenamic acid also causes a decrease in the formation of thromboxane A2 synthesis, by thromboxane synthase, thereby inhibiting platelet aggregation.

FDA_UNII_Code

367589PJ2C

FULL_SYN

2-((2,3-Dimethylphenyl)amino)benzoic Acid

Anthranilic Acid, N-2,3-xylyl-

MEFENAMIC ACID

Mefenamic Acid

Ponstel

label

Mefenamic Acid

Legacy Concept Name

Mefenamic_Acid

NSC Number

94437

Preferred_Name

Mefenamic Acid

prefixIRI

Thesaurus:C47599

PubMedID_Primary_Reference

2242038

Semantic_Type

Pharmacologic Substance

UMLS_CUI

C0025152

subClassOf

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C257

Delete Subject Author Type Created
No notes to display
Create mapping

Delete Mapping To Ontology Source
http://purl.obolibrary.org/obo/CHEBI_6717 HOIP LOOM
http://purl.obolibrary.org/obo/CHEBI_6717 CHEBI LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#7878 OCHV LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D008528 RH-MESH LOOM
http://stirdf.jst.go.jp/id/200907001718435990 IOBC LOOM
http://purl.obolibrary.org/obo/CHEBI_6717 PDRO LOOM
http://purl.obolibrary.org/obo/CHEBI_6717 FIDEO LOOM
http://purl.obolibrary.org/obo/CHEBI_6717 BERO LOOM
http://purl.obolibrary.org/obo/CHEBI_6717 TXPO LOOM
http://purl.obolibrary.org/obo/OMIT_0009594 OMIT LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#C0025152 OCHV LOOM
http://purl.bioontology.org/ontology/NDDF/001578 NDDF LOOM
http://purl.bioontology.org/ontology/ATC/M01AG01 ATC LOOM
http://purl.obolibrary.org/obo/MESH_D008528 BERO LOOM
http://purl.obolibrary.org/obo/NCIT_C47599 BERO LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D02.241.223.100.050.400.200.555 RH-MESH LOOM
http://scai.fraunhofer.de/AlzheimerOntology#mefenamic_acid ADO LOOM
http://purl.obolibrary.org/obo/dinto_DB00784 DINTO LOOM
http://purl.bioontology.org/ontology/RCD/x02MP RCD LOOM
http://www.drugbank.ca/drugs/DB00784 FTC LOOM
http://purl.bioontology.org/ontology/MESH/D008528 MESH LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D02.455.426.559.389.127.020.906.750.555 RH-MESH LOOM
https://go.drugbank.com/drugs/DB00784 MDM LOOM
http://www.phoc.org.cn/pmo/class/PMO_00016503 PMAPP-PMO LOOM
http://purl.bioontology.org/ontology/VANDF/4019082 VANDF LOOM
http://purl.jp/bio/4/id/200906054671735225 IOBC LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/387185008 SNOMEDCT LOOM
http://purl.bioontology.org/ontology/SNMI/C-60400 SNMI LOOM
http://purl.bioontology.org/ontology/RXNORM/6693 RXNORM LOOM
http://purl.bioontology.org/ontology/NDFRT/N0000147343 NDFRT LOOM
http://www.co-ode.org/ontologies/galen#MefenamicAcid GALEN LOOM